Preclinical data for infectious disease vaccines and therapeutics
KPC10000394
-
AccessionKPC10000394
-
Submission date2025-09-10
Project Detail
|
Accession
|
KAP241597 |
|---|---|
|
Project title
|
Covid-19 Preclinical Testing (2025)
|
|
Project title in Korean
|
Covid-19 전임상 시험(2025)
|
|
Project description
|
The data generated from the preclinical testing in the "Covid-19 Preclinical Testing" project encompasses a comprehensive set of parameters crucial for evaluating the efficacy and safety of treatment and vaccine candidates. This includes meticulous measurements such as body weight, body temperature, and survival rates, providing vital insights into the overall health and response of the model organisms to the tested interventions. The systematic collection and analysis of this data contribute significantly to shaping the development trajectory of potential Covid-19 treatments and vaccines.
|
|
Project description in Korean
|
치료제 및 백신 후보물질의 효능 및 안전성 평가를 통해 생성된 데이터를 포함함. 체중, 체온 및 생존률과 같은 측정치가 포함되어 후보물질에 대한 모델동물의 생체 반응을 분석할 수 있음. 데이터의 체계적인 수집과 분석을 통해 Covid-19 치료제 및 백신의 개발에 기여함.
|
|
Umbrella Project
|
KAP100010 (Covid-19 Preclinical Testing) |
Metadata
|
데이터 타입
|
Preclinical data for infectious disease vaccines and therapeutics |
|---|---|
|
Test data type
|
백신 |
|
Infectious agent classification
|
Virus |
|
Target agent name
|
SARS-CoV-2 |
|
Candidate material type
|
단백질/펩타이드 제제 |
|
Study type
|
기타(in vivo) - 바이러스역가 |
Related data
KPC
-
감염병 백신 및 치료제 전임상 시험 데이터
File